Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled...

por Marmouz, Farid, Giralt, Josep, Izquierdo, Iñaki
Publicado 2011

Rupatadine Oral Solution Titration by Body Weight in Paediatric Patients Suffering from Allergic Rhinitis: A Population Pharmacokinetic Study

por Santamaria, Eva, Izquierdo, Iñaki, Valle, Marta
Publicado 2021

Rupatadine oral solution for 2–5-year-old children with allergic rhinitis: a safety, open-label, prospective study

por Santamaría, Eva, Izquierdo, Iñaki, Valle, Marta, Vermeulen, Jan, Potter, Paul
Publicado 2018

PD39 - Application of population pharmacokinetic modeling and simulation in the design of the optimal dose regime of rupatadine in children 2-5 year old children

por Valle, Marta, Estevez, Javier, Martial, Lisa Charlotte, Santamaria, Eva, Izquierdo, Iñaki
Publicado 2014

Population pharmacokinetic modelling of rupatadine solution in 6–11 year olds and optimisation of the experimental design in younger children

por Santamaría, Eva, Estévez, Javier Alejandro, Riba, Jordi, Izquierdo, Iñaki, Valle, Marta
Publicado 2017

Pharmacokinetics, Safety and Cognitive Function Profile of Rupatadine 10, 20 and 40 mg in Healthy Japanese Subjects: A Randomised Placebo-Controlled Trial

por Täubel, Jörg, Ferber, Georg, Fernandes, Sara, Lorch, Ulrike, Santamaría, Eva, Izquierdo, Iñaki
Publicado 2016

Clinically relevant effect of rupatadine 20 mg and 10 mg in seasonal allergic rhinitis: a pooled responder analysis

por Mullol, Joaquim, Izquierdo, Iñaki, Okubo, Kimihiro, Canonica, Giorgio Walter, Bousquet, Jean, Valero, Antonio
Publicado 2019

Higher efficacy of rupatadine 20 mg and 10 mg versus placebo in patients with perennial allergic rhinitis: a pooled responder analysis

por Valero, Antonio, Izquierdo, Iñaki, Kowalski, Marek L., Scadding, Glenis K., Bousquet, Jean, Mullol, Joaquim
Publicado 2020

Rupatadine in Established Treatment Schemes Improves Chronic Spontaneous Urticaria Symptoms and Patients’ Quality of Life: a Prospective, Non-interventional Trial

por Metz, Martin, Weller, Karsten, Neumeister, Claudia, Izquierdo, Iñaki, Bödeker, Rolf-Hasso, Schwantes, Ulrich, Maurer, Marcus
Publicado 2015

O10 - Rupatadine is effective and safe in the treatment of Chronic Spontaneous Urticaria (CSU) in pediatric patients (2-11 years old)

por Potter, Paul, Mitha, Essack, Barkai, Laszlo, Domenech, Alejandro, Santamaria, Eva, Giralt, Josep, Izquierdo, Iñaki, Maurer, Marcus
Publicado 2014

Rupatadine oral solution improves rhino-conjunctive symptoms control in children with 6-11 years weighing ≥25 kg with persistent allergic rhinitis

por Izquierdo, Iñaki, Potter, Paul, Maspero, Jorge, Vermeulen, Jan, Barkai, Laszlo, Nemeth, Ildiko, Baillieau, Rene, Garde M, Jesus M, Giralt, Josep, Domenech, Alejandro, Nieto, Antonio
Publicado 2013